Skip to content
Screener

Pfizer PFE Dividends Paid

Discontinued — last reported Q4 '25

Dividends Paid at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$1.29B+2.0%
Eli Lilly logo
Eli LillyLLY
$1.55B+15.0%
Merck & Co. logo
Merck & Co.MRK
$2.11B+2.7%
Amgen logo
AmgenAMGN
$1.36B+6.2%
AbbVie logo
AbbVieABBV
$3.09B+5.5%
Organon logo
OrganonOGN
$5M-93.0%

Other financials

Income statement

See full
Revenue$15.0B+2.6%
Gross profit$10.9B+0.6%
Net income-$248.0M-109%
EPS (diluted)-$0.04-108%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$142.54B+6.6%
Enterprise value$205.21B+9.2%
P/E16×
P/S2.2×+0.1×

Profitability

See full
Gross margin73.2%+1.1pp
Net margin15.7%
FCF margin18%+8.8pp

Returns & leverage

See full
Return on equity10.6%
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfOrdinaryDividends.

The source filing: Pfizer’s 10-K, filed February 26, 2026.

Filed
Feb 26, 2026, 12:44 PM EST
Fiscal year
FY2025
Accession
0000078003-26-000026
(MILLIONS)Year Ended December 31, 2025Year Ended December 31, 2024Year Ended December 31, 2023
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less(796)(2,590)3,161
Proceeds from issuance of long-term debt9,67830,831
Payments on long-term debt(6,757)(2,250)(2,569)
Cash dividends paid(9,771)(9,512)(9,247)
Other financing activities, net(458)(469)(631)
Net cash provided by/(used in) financing activities(10,304)(17,140)26,066
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents41(66)(40)
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents91(1,810)2,448

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Pfizer's dividends paid?
Pfizer (PFE) reported dividends paid of $2.45B in Q4 2025.
How has Pfizer's dividends paid changed year-over-year?
Pfizer's dividends paid increased by 2.7% year-over-year, from $2.38B to $2.45B.
What is the long-term trend for Pfizer's dividends paid?
Over 4 years (2021 to 2025), Pfizer's dividends paid has grown at a 2.9% compound annual growth rate (CAGR), from $8.73B to $9.77B.
What does dividends paid mean?
Total cash dividends paid to common stockholders, reflecting the company's capital return policy.

Ask your AI about Pfizer's dividends paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude